CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 27 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,211,000 | +419.7% | 1,423,000 | +469.2% | 0.08% | +710.0% |
| Q3 2018 | $233,000 | -98.2% | 250,000 | -97.9% | 0.01% | -98.3% |
| Q2 2018 | $12,653,000 | +107.0% | 11,752,000 | +123.8% | 0.59% | +94.7% |
| Q1 2018 | $6,112,000 | -27.5% | 5,251,000 | -16.0% | 0.30% | -26.7% |
| Q4 2017 | $8,433,000 | +4.0% | 6,251,000 | +19.0% | 0.42% | +4.8% |
| Q3 2017 | $8,112,000 | -56.3% | 5,251,000 | -52.0% | 0.40% | -56.0% |
| Q2 2017 | $18,558,000 | -7.0% | 10,950,000 | -29.1% | 0.90% | -24.6% |
| Q1 2017 | $19,951,000 | +269.3% | 15,450,000 | +194.3% | 1.20% | +305.1% |
| Q4 2016 | $5,402,000 | +214.6% | 5,250,000 | +162.5% | 0.30% | +189.2% |
| Q4 2015 | $1,717,000 | -93.1% | 2,000,000 | -86.7% | 0.10% | -93.1% |
| Q3 2015 | $24,988,000 | – | 15,000,000 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 49,064,000 | $44,037,000 | 1.28% |
| United Asset Strategies, Inc. | 1,955,000 | $1,758,000 | 0.35% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,992,000 | $1,773,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,664,000 | $2,398,000 | 0.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,170,000 | $1,953,000,000 | 0.04% |
| MACKAY SHIELDS LLC | 110,000 | $101,000 | 0.00% |
| UBS Group AG | 3,000 | $3,000 | 0.00% |
| NOMURA HOLDINGS INC | 68,267 | $5,000 | 0.00% |
| ROYAL BANK OF CANADA | 1,000 | $1,000 | 0.00% |
| FMR LLC | 1,728,000 | $1,556,000 | 0.00% |